Q1 2026 · 13F-HR/A
Kalehua Capital Management LLCholdings as filed
Filed 2026-05-15 · accession 0002106181-26-000005
$141.3M
Reported value
25
Positions
2026-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 02072L565 | BOXX | EA SERIES TRUST | $25.4M | 18.0% | 218,278 | Common | SOLE |
| 98420X202 | XFOR | X4 Pharmaceuticals Inc | $15.4M | 10.9% | 3,722,840 | Common | SOLE |
| 86889P208 | SRZN | Surrozen Inc | $11.2M | 7.94% | 385,178 | Common | SOLE |
| 922967104 | MANE | VERADERMICS INC | $9.2M | 6.51% | 145,695 | Common | SOLE |
| 75943R102 | RLAY | Relay Therapeutics Inc | $9.0M | 6.35% | 901,457 | Common | SOLE |
| 829401108 | SION | Sionna Therapeutics Inc | $7.9M | 5.59% | 197,072 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $6.9M | 4.86% | 1,832,365 | Common | SOLE |
| 45719W205 | IKT | Inhibikase Therapeutics Inc | $6.4M | 4.54% | 3,821,890 | Common | SOLE |
| 687604108 | ORKA | Oruka Therapeutics Inc | $5.8M | 4.11% | 118,524 | Common | SOLE |
| N69605108 | PHVS | Pharvaris NV | $5.6M | 3.97% | 198,772 | Common | SOLE |
| N90064101 | QURE | Uniqure NV | $4.8M | 3.37% | 291,109 | Common | SOLE |
| 81734D104 | SEPN | Septerna Inc | $4.7M | 3.31% | 194,544 | Common | SOLE |
| 20451W101 | CMPS | Compass Pathways PLC | $4.5M | 3.21% | 819,692 | Common | SOLE |
| 04746L203 | LONA | LeonaBio Inc | $4.0M | 2.86% | 393,701 | Common | SOLE |
| 36322Q206 | DMRA | Damora Therapeutics Inc | $3.6M | 2.55% | 139,000 | Common | SOLE |
| 38341P102 | GOSS | Gossamer Bio Inc | $3.4M | 2.38% | 10,236,293 | Common | SOLE |
| 61559X104 | MLTX | MoonLake Immunotherapeutics | $3.3M | 2.32% | 175,734 | Common | SOLE |
| 90240B106 | TYRA | Tyra Biosciences Inc | $2.9M | 2.02% | 74,465 | Common | SOLE |
| 713317105 | PEPG | PepGen Inc | $1.8M | 1.25% | 1,000,000 | Common | SOLE |
| 45783C200 | TIL | Instil Bio Inc | $1.5M | 1.07% | 183,030 | Common | SOLE |
| 87990A106 | TNYA | Tenaya Therapeutics Inc | $1.4M | 0.98% | 2,000,000 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $1.2M | 0.88% | 109,376 | Common | SOLE |
| 482929106 | KLRS | Kalaris Therapeutics Inc | $782,325 | 0.55% | 135,585 | Common | SOLE |
| 25253X207 | DMAC | DiaMedica Therapeutics Inc | $423,044 | 0.30% | 62,488 | Common | SOLE |
| 543518104 | LOOP | LONGEVERON INC | $361,441 | 0.26% | 347,539 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.